PubRank

H Kameda

Author PubWeight™ 47.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. Ann Rheum Dis 2010 2.04
2 Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis. J Rheumatol 1996 1.43
3 Successful treatment with cyclosporin A of pure red cell aplasia associated with rheumatoid arthritis. J Rheumatol 1996 1.37
4 Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther 2007 1.28
5 Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab. Rheumatology (Oxford) 2008 1.17
6 Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Rheumatology (Oxford) 2008 1.16
7 Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982 1.09
8 Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med 1999 0.99
9 Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology 1993 0.99
10 Functional and histological injury to intestinal mucosa produced by hypertonicity. Am J Physiol 1968 0.98
11 A GATA binding site is involved in the regulation of 15-lipoxygenase-1 expression in human colorectal carcinoma cell line, caco-2. FEBS Lett 2000 0.96
12 Hepatic venography in noncirrhotic idiopathic portal hypertension. Comparison with cirrhosis of the liver. Radiology 1981 0.94
13 Adenomyoma of the common hepatic duct. J Gastroenterol 1995 0.92
14 Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines. Hepatogastroenterology 1990 0.92
15 Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells. Exp Cell Res 2001 0.88
16 Human bile duct carcinoma cell line producing abundant mucin in vitro. Gastroenterol Jpn 1987 0.88
17 [A case of spotted fever with central nervous system involvement]. Kansenshogaku Zasshi 1988 0.87
18 Detection of fibronectin receptor in sera: its clinical significance as a parameter of hepatic fibrosis. Hepatology 1991 0.87
19 Development of a second generation monoclonal immunoradiometric assay. Increased sensitivity leads to enhanced detection of hepatitis B viral infection. J Immunol Methods 1988 0.87
20 Methotrexate treatment in patients with adult onset Still's disease--retrospective study of 13 Japanese cases. Ann Rheum Dis 1997 0.86
21 The binding of indocyanine green and other organic anions to serum proteins in liver diseases. Clin Chim Acta 1974 0.83
22 Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis. J Rheumatol 1997 0.83
23 An epidemic of non-A, non-B hepatitis in Japan. Am J Gastroenterol 1983 0.83
24 Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice. Lupus 2009 0.81
25 [An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers]. Gan No Rinsho 1983 0.81
26 [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis]. Ryumachi 1997 0.81
27 Experimental study on thermal damage to dog normal brain. Int J Hyperthermia 1994 0.81
28 [Establishment and characterization of a human gall bladder carcinoma cell line NOZ]. Hum Cell 1988 0.81
29 Anatomical basis of hepatic venographic alterations in idiopathic portal hypertension. Liver 1981 0.80
30 Measurement of 14C-lactose absorption in the diagnosis of lactase deficiency. J Lab Clin Med 1970 0.80
31 [Coexistence of brain tumors and cerebral aneurysms --clinical considerations from eight cases (author's transl)]. Neurol Med Chir (Tokyo) 1981 0.80
32 [Effects of TNF on human hepatocellular carcinoma cell lines and their modification by hyperthermia]. Hum Cell 1988 0.80
33 [Histochemical examination of gastric covering and epithelial mucus in rats. Effect of several drugs on gastric mucus]. Nihon Shokakibyo Gakkai Zasshi 1984 0.80
34 Infrasellar craniopharyngioma. Neuroradiology 1989 0.79
35 Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers. Eur J Pharmacol 1999 0.79
36 Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR Am J Roentgenol 1980 0.79
37 Sphenoethmoidal mucoceles with intracranial extension--three case reports. Neurol Med Chir (Tokyo) 1996 0.78
38 Clinical characteristics related to methotrexate-induced pancytopenia. Clin Rheumatol 1997 0.78
39 [Protein secretion of human cultured liver cells]. Hum Cell 1988 0.78
40 The effect of alpha-linolenic acid-rich emulsion on fatty acid metabolism and leukotriene generation of the colon in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996 0.77
41 Retinol transport in cultured fat-storing cells of rat liver. Quantitative analysis by anchored cell analysis and sorting system. Lab Invest 1989 0.77
42 A difference in mode of antagonism between optical isomers of a potent selective alpha 1-adrenoceptor blocker (YM-12617) and norepinephrine in isolated rabbit iris dilator and aorta. Jpn J Pharmacol 1986 0.77
43 A clinical study on gallstones in Bolivia. Jpn J Med 1983 0.77
44 [Establishment and characterization of a human hepatocellular carcinoma cell line JHH-4]. Hum Cell 1988 0.77
45 The development of clinical studies in cholelithiasis. Intern Med 1993 0.77
46 Expression of sex-hormone receptors and clinicopathological findings in hepatocellular-carcinoma. Int J Oncol 1994 0.77
47 Therapeutic effects of tiopronin on chronic hepatitis: a double-blind clinical study. J Int Med Res 1982 0.77
48 [Establishment of the human hepatocellular carcinoma cell line and its characteristics]. Hum Cell 1988 0.77
49 The linoleic acid metabolite, 13-HpODE augments the phosphorylation of EGF receptor and SHP-2 leading to their increased association. Prostaglandins Leukot Essent Fatty Acids 1999 0.77
50 Clinical and nutritional study on gallstone disease in Japan. Jpn J Med 1984 0.77
51 [Establishment and characterization of a human hepatocellular carcinoma cell line JHH-7 producing alpha -fetoprotein and carcinoembryonic antigen--changes in secretion of AFP and CEA from JHH-7 cells after heat treatment]. Hum Cell 1990 0.77
52 Ammonia potentiates GABAA response in dissociated rat cortical neurons. Neurosci Lett 1993 0.76
53 [Establishment and characterization of human pancreatic adenocarcinoma cell line JHP-1 producing carbohydrate antigen 19-9 and carcinoembryonic antigen]. Hum Cell 1988 0.76
54 Major depressive episode and low dose dexamethasone suppression test. Folia Psychiatr Neurol Jpn 1982 0.76
55 [Gonadal function in young female affective illness associated with the menstrual cycle--in relation to the polycystic ovary syndrome]. Seishin Shinkeigaku Zasshi 1992 0.76
56 Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus. Rheumatology (Oxford) 2008 0.75
57 [Sjogren's syndrome: report of a case]. Kyoto Daigaku Kokukagaku Kiyo 1966 0.75
58 Model studies on percutaneous absorption and transport in the ointment. I. Theoretical aspects. Chem Pharm Bull (Tokyo) 1975 0.75
59 The morphological studies on characteristics of isolated parenchymal and non-parenchymal cells of the rat liver. J Electron Microsc (Tokyo) 1982 0.75
60 [Lipoprotein X and alcohol dehydrogenase]. Nihon Rinsho 1979 0.75
61 [A study of antibody dependent cell-mediated cytotoxicity in patients with chronic active hepatitis (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1981 0.75
62 Reconstruction for the vertebral artery stenosis at its origin--bypass surgery using a saphenous vein graft with external shunting. Neurol Med Chir (Tokyo) 1990 0.75
63 [Pitfalls in the psychological support in nursing]. Kurinikaru Sutadi 1987 0.75
64 [Liver cirrhosis (coma)]. Naika 1970 0.75
65 Effects of labetalol on in vitro preparations of the trachea and lung strips and on ventilation overflow in vivo in guinea pigs. Jpn J Pharmacol 1987 0.75
66 Ultrasound imaging for stereotactic evacuation of hypertension-associated intracerebral hematomas with aqua-stream and aspiration. Stereotact Funct Neurosurg 1993 0.75
67 [Laboratory examinations in emergency cases: urinary urobilinogen]. Naika 1965 0.75
68 [Gallstone disease and cholangitis]. Nihon Rinsho 1970 0.75
69 [Psychosomatic study on diseases of the large intestine]. Naika 1969 0.75
70 [Clinical evaluation of CA 19-9, TPA, IAP and 5'-NPD-V as tumor markers of hepatocellular, bile duct and pancreas carcinoma]. Gan No Rinsho 1985 0.75
71 Effects of Ca2+ antagonists and antiepileptics on tetrodotoxin-sensitive Ca(2+)-conducting channels in isolated rat hippocampal CA1 neurons. Neurosci Lett 1992 0.75
72 The development of immunological studies in hepatitis. Jpn J Med 1991 0.75
73 [Chief complaints: mild fever and general malaise]. Naika 1967 0.75
74 [Liver diseases and colonic dysfunction]. Nihon Rinsho 1988 0.75
75 The nutritional effect of a-linolenic acid-rich emulsion with total parenteral nutrition in a rat model with inflammatory bowel disease. Ann Nutr Metab 1996 0.75
76 [Multiple organ involvement in liver cirrhosis]. Kango Gijutsu 1982 0.75
77 [The effect of flashing light on the alpha activities in patients with and without neurological diseases: responses to sporadic flashes]. Seishin Shinkeigaku Zasshi 1965 0.75
78 The effects of recombinant interleukin 2 on HBe antigen positive chronic hepatitis B. Jpn J Med 1991 0.75
79 [Diagnosis and management of obstructive jaundice]. Nihon Ishikai Zasshi 1969 0.75
80 [B cell function in acute and chronic liver diseases (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1982 0.75
81 Detection of hepatitis B virus infection in hepatitis B surface antigen-negative hemodialysis patients by monoclonal radioimmunoassays. Gastroenterology 1986 0.75
82 [The effect of local administration of recombinant interleukin-2 (rIL-2) on metastatic gastric tumor: report of an autopsy case]. Nihon Gan Chiryo Gakkai Shi 1989 0.75
83 [Radioisotope scanning of the liver and spleen in cases of schistosomiasis japonica]. Naika 1970 0.75
84 [Mirizzi's syndrome]. Nihon Rinsho 1978 0.75
85 [Auriculotemporal syndrome: a case treated by excision of the skin]. Kyoto Daigaku Kokukagaku Kiyo 1966 0.75
86 [Round table conference: clinical aspects of biliary diseases]. Naika 1971 0.75
87 [Effects of labetalol on the circulatory system (author's transl)]. Nihon Yakurigaku Zasshi 1980 0.75
88 [Successful treatment of toe gangrene with moderate-dose steroid therapy in a patient with systemic sclerosis (CREST syndrome)]. Ryumachi 1997 0.75
89 [Significance of splenic blood flow volume in portal hypertension, with special reference to idiopathic portal hypertension]. Saishin Igaku 1969 0.75
90 Abnormal prostanoid metabolism in systemic lupus erythematosus with pulmonary hypertension. J Rheumatol 1994 0.75
91 [Clinico-internal conference: No. 158. Chief complaints: gingival bleeding, nasal bleeding and fever]. Naika 1970 0.75
92 Inhibitory effect of nicotine on chemiluminescence response of human polymorphonuclear leukocytes stimulated by opsonized zymosan in vitro. J Toxicol Sci 1984 0.75
93 [CPC 156. Chief complaints: ascites and edema]. Naika 1969 0.75
94 [Cholelithiasis and cholecystitis - lists of statistics pertinent to diagnosis]. Nihon Rinsho 1974 0.75
95 [Examination of the effects of hyperthermia and anticancer agent on cultured human gall bladder cancer cells by DNA fluorimetric assay]. Gan To Kagaku Ryoho 1989 0.75
96 [Primary malignant melanoma of the oral cavity: report of four cases]. Kyoto Daigaku Kokukagaku Kiyo 1967 0.75
97 [Idiopathic (non-cirrhotic) portal hypertension. II. Hemodynamics of the liver and spleen]. Naika 1968 0.75
98 Model studies on percutaneous absorption and transport in the ointment. II. Hydrophilic ointment of NaI. Chem Pharm Bull (Tokyo) 1975 0.75
99 [Fever, hypocondriac pain]. Naika 1965 0.75
100 The effect of bilirubin on biliary lipid secretion: analysis by horseradish peroxidase associated intrahepatic vesicular transport system. Gastroenterol Jpn 1988 0.75
101 [A case with pentazocine dependence developing delirium on withdrawal (author's transl)]. Seishin Shinkeigaku Zasshi 1979 0.75
102 [Effects of hyperthermia on the proliferation and viability of cultured human hepatobiliary carcinoma cells]. Nihon Shokakibyo Gakkai Zasshi 1985 0.75
103 [Diagnosis of chronic liver diseases by radioisotope scanning]. Naika 1969 0.75
104 Quantification of human serum ligandin by radioimmunoassay. Clin Chim Acta 1978 0.75
105 [Undifferentiated sarcoma of the liver--its histopathological peculiarities]. Nihon Shokakibyo Gakkai Zasshi 1988 0.75
106 [Case of MPO-ANCA positive interstitial pneumonitis and necrotizing, crescentic glomerulonephritis]. Ryumachi 1996 0.75
107 [Combination therapy of hyperthermia and other methods in liver and bile tract cancers--evaluation of these methods using cancer cell lines in vitro]. Gan To Kagaku Ryoho 1989 0.75
108 [Intra-arterial infusion chemotherapy: clinical applications and current status of therapeutic effects on various malignant tumors]. Gan To Kagaku Ryoho 1989 0.75
109 [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis]. Ryumachi 1995 0.75
110 [Significance of serum CEA in a case of ileal cancer]. Nihon Shokakibyo Gakkai Zasshi 1984 0.75
111 [Primary lactose intolerance in adults and its etiology]. Nihon Rinsho 1972 0.75
112 [Liver cell culture and physiopathology of the liver]. Nihon Rinsho 1978 0.75
113 [The defensive effect of gastric mucus against carcinogenesis. Quantitative measurement of incorporation of N-[methyl-3H]-N'-nitro-N-nitrosoguanidine into gastric mucosal DNA]. Nihon Shokakibyo Gakkai Zasshi 1985 0.75
114 Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs. Arch Int Pharmacodyn Ther 1993 0.75
115 Splenic blood flow in idiopathic portal hypertension in Japan measured by 85Kr clearance method. Acta Hepatosplenol 1971 0.75
116 [Anaphylatoxin in the aqueous humor of rabbit with endotoxin induced endophthalmitis]. Nippon Ganka Gakkai Zasshi 1989 0.75
117 [The efficacy of combination therapy with prednisolone (PSL) and methotrexate (MTX) on radiographic progression in patients with rheumatoid arthritis (RA)]. Ryumachi 1998 0.75
118 [Relationship between gallbladder cancer and cholelithiasis]. Nihon Rinsho 1972 0.75
119 [Postcholecystectomy syndrome]. Nihon Rinsho 1977 0.75
120 [Pharmacophysiological functions of bile acids]. Nihon Rinsho 1984 0.75
121 Effect of gastric mucus on the uptake of the carcinogen MNNG by gastric mucosal DNA. J Clin Gastroenterol 1990 0.75
122 [A study on the mechanism of the antiasthmatic effect of labetalol on experimental histamine-induced asthma]. Nihon Yakurigaku Zasshi 1986 0.75
123 [Methotrexate therapy in rheumatoid arthritis]. Ryumachi 1991 0.75
124 Diagnosis and differentiation of constitutional hyperbilirubinemias using sequential scanning with 131-I-BSP (monoiodide). J Nucl Med 1971 0.75
125 [A case of systemic lupus erythematosus associated with spinal epidural hematoma]. Nihon Rinsho Meneki Gakkai Kaishi 1998 0.75
126 [Progress in diagnosis and therapeutic systems in cholelithiasis]. Nihon Rinsho 1987 0.75
127 [Case of portal hypertension presenting as Cruveilhier-Baumgarten syndrome and an unusual angiogram]. Naika 1968 0.75
128 Glucocorticoid-unresponsive fever in a patient with Weber-Christian disease. Br J Clin Pract 1994 0.75
129 [Complication of liver cirrhosis with cholelithiasis]. Nihon Rinsho 1973 0.75
130 Guanase activity in the donor serum and the incidence of posttransfusion hepatitis non-A, non-B. Ann Acad Med Singapore 1986 0.75
131 [C.P.C. No. 154 chief complaints: pallor and fatigue]. Naika 1969 0.75
132 [Floating gallbladder calculi and its clinical significance]. Nihon Shokakibyo Gakkai Zasshi 1972 0.75
133 Characterization of alpha-fetoprotein secreted from cultured reuber H-35 hepatoma cells. In Vitro 1982 0.75
134 [Detection of hepatitis B virus infection in HBsAg-negative hemodialysis patients by first generation and newly developed second generation monoclonal radioimmunoassays]. Nihon Jinzo Gakkai Shi 1987 0.75
135 [Comparative study of primary liver cancer in Japan and Taiwan]. Nihon Rinsho 1968 0.75
136 [Physiopathology of cholelithiasis]. Saishin Igaku 1965 0.75
137 [Drug therapy of cholelithiasis and cholecystitis]. Naika 1967 0.75
138 [Symposium on idiopathic portal hypertension. 3. Pathophysiology of idiopathic portal hypertension]. Nihon Naika Gakkai Zasshi 1968 0.75
139 [Measurement of hepatic plasma volume using Tc 99m albumin by double injection-single sampling method (author's transl)]. Kaku Igaku 1979 0.75
140 Heterotopic gastric mucosa of the gallbladder. J Gastroenterol 1995 0.75
141 [Definition and classification of toxic hepatitis]. Nihon Rinsho 1985 0.75
142 [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis]. Nihon Shokakibyo Gakkai Zasshi 1983 0.75
143 [The present state of cholelithiasis research in Japan (author's transl)]. Leber Magen Darm 1976 0.75
144 [Chief complaints: abdominal pain and melana]. Naika 1967 0.75
145 [Medical treatment of cholelithiasis and bile duct cancer]. Nihon Naika Gakkai Zasshi 1988 0.75
146 [Complaints after surgery of cholelithiasis--postcholecystectomy syndrome]. Geka Chiryo 1969 0.75
147 Morphological characteristics of human fat-storing cells fractionated and cultured by newly techniques. Hum Cell 1989 0.75
148 [Speech disorders and palpitations]. Naika 1968 0.75
149 [A case of B-cell non-Hodgkin's lymphoma with prominent splenomegaly and high serum titer of cold agglutinin]. Gan No Rinsho 1990 0.75
150 [Round table conference. Current status of internal medicine]. Naika 1966 0.75
151 [Chiari's disease and the Budd-Chiari syndrome]. Naika 1968 0.75
152 [Chronic bile duct diseases]. Nihon Rinsho 1971 0.75
153 Natural course of gallstones. Gastroenterol Jpn 1979 0.75
154 [An application of universal determination of body fluid protein-concentration. II. 131-I-BSP binding human serum proteins (author's transl)]. Rinsho Byori 1973 0.75
155 [Case of upper mesenteric artery syndrome of the duodenum]. Naika 1966 0.75
156 A comparison of the beta-adrenoceptor agonist potency of labetalol with those of sympathomimetic drugs, and the role of alpha-receptors in pharmacological actions of these drugs on tracheal smooth muscles in guinea pigs. Chem Pharm Bull (Tokyo) 1986 0.75
157 [Autoimmune hepatitis]. Nihon Naika Gakkai Zasshi 1990 0.75
158 Effects of ranitidine on plasma clearance of indocyanine green in patients with liver cirrhosis. Gastroenterol Jpn 1987 0.75
159 [Medical treatment of cholelithiasis]. Naika 1965 0.75
160 [Classification of the isolated hepatocytes]. Hum Cell 1988 0.75
161 [Idiopathic (non-cirrhotic) portal hypertension. Banti's syndrome. 1]. Naika 1968 0.75
162 [C.P.C. No. 155. Chief complaint: pyrexia, edema and sweilling of lymph nodes]. Naika 1969 0.75
163 [Pathophysiology and drug therapy of bile duct diseases]. Nihon Ishikai Zasshi 1970 0.75
164 [Clinical conference of internal medicine. No. 160. Chief complaints in feeling of fatigue, vomiting and headache]. Naika 1970 0.75
165 [Digestive organs]. Naika 1972 0.75
166 [Clinical significance of tissue polypeptide antigen as a tumor marker]. Nihon Rinsho 1990 0.75
167 [An autopsy case of hepatocellular carcinoma invaded into ligamentum teres hepatis]. Nihon Shokakibyo Gakkai Zasshi 1989 0.75
168 [Pathophysiology and clinical features of gallstone disease]. Nihon Naika Gakkai Zasshi 1989 0.75
169 [Primary malignant lymphoma of the brain following immunosuppressive therapy of systemic lupus erythematosus]. Nihon Naika Gakkai Zasshi 1987 0.75
170 [Surgical treatment of chronic constipation with megarectum in children]. Nihon Geka Gakkai Zasshi 1986 0.75
171 Detection of hepatic shunts by the use of 131-I-macroaggregated albumin. Gastroenterology 1967 0.75
172 [Studies on K-cell population in peripheral blood from patients with liver diseases (author's transl)]. Nihon Shokakibyo Gakkai Zasshi 1980 0.75
173 [Postcholecystectomy syndrome and countermeasures for refractory cases]. Naika 1969 0.75
174 [X-ray examination using artificial pneumoperitoneum]. Naika 1966 0.75
175 [Clinical picture and prognosis of liver cirrhosis]. Naika 1969 0.75
176 [Histochemical examination of gastric covering and epithelial mucus in rats (the 2nd report). Effect of several anti-ulcer drugs on aspirin-induced mucosal damage]. Nihon Shokakibyo Gakkai Zasshi 1985 0.75
177 [A case report of secondary Budd-Chiari syndrome due to chronic empyema diagnosed by NMR-CT]. Nihon Naika Gakkai Zasshi 1985 0.75
178 [Epidemiology of cholelithiasis--regional characteristics of cholelithiasis in Japan and foreign countries]. Kango Gijutsu 1977 0.75
179 [The classification and treatment of acute hepatitis]. Kango Gijutsu 1984 0.75
180 [Adrenocortical steroid therapy of hematologic diseases and peptic ulcer]. Nihon Rinsho 1971 0.75
181 [Dyspnea and pain of the anterior thoracic region (ECG): (myocardial infarct) formation of ventricular aneurysm)]. Nihon Rinsho 1977 0.75
182 Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease. Enzyme 1984 0.75
183 [First aid in cholelithiasis and diaphragmatic hernia]. Naika 1968 0.75
184 [Carcinoma of the gallbladder associated with cholelithiasis]. Naika 1965 0.75
185 [Chronic cholecystitis]. Shujutsu 1971 0.75
186 Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis. Adv Exp Med Biol 1997 0.75
187 Rate of release of medicaments from ointment bases containing drugs in suspension. Chem Pharm Bull (Tokyo) 1975 0.75
188 [Arterial infusion of antineoplastic agents in neoplasms of liver, biliary tract and pancreas--one shot method and continuous infusion]. Nihon Rinsho 1982 0.75